Skip to main content

Table 1 Patient characteristics according to the PET/CT SUVmax at different treatment time points

From: Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma

Variable

Baseline SUVmax

P value

Mid-therapy SUVmax

P value

Post-therapy SUVmax

P value

n

Mean ± SD

n

Mean ± SD

n

Mean ± SD

Age

  

0.073

  

0.489

  

0.695

 <60 years

20

18.5 ± 8.5

 

13

4.1 ± 4.9

 

14

3.2 ± 3.9

 

 ≥60 years

3

7.1 ± 2.6

 

2

6.3 ± 7.4

 

3

2.7 ± 4.6

 

Sex

  

0.357

  

0.595

  

0.411

 Male

17

17.5 ± 8.5

 

11

4.0 ± 3.6

 

13

3.0 ± 2.6

 

 Female

6

15.5 ± 10.3

 

4

5.3 ± 8.4

 

4

3.6 ± 7.3

 

B symptoms

  

1.000

  

0.953

  

1.000

 Yes

8

17.7 ± 9.1

 

7

3.3 ± 3.0

 

8

2.7 ± 2.5

 

 No

15

16.6 ± 9.0

 

8

5.3 ± 6.3

 

9

3.5 ± 5.0

 

Bulky diseasea

  

0.069

  

0.293

  

0.164

 Yes

4

24.1 ± 5.6

 

3

1.8 ± 3.1

 

2

4.7 ± 0.6

 

 No

19

15.5 ± 8.8

 

12

5.0 ± 5.2

 

15

2.9 ± 4.1

 

ECOG scores

  

0.014

  

0.631

  

0.363

 <2

14

13.4 ± 7.6

 

9

5.2 ± 5.8

 

10

3.0 ± 4.8

 

 ≥2

9

22.6 ± 8.0

 

6

3.1 ± 3.4

 

7

3.3 ± 2.4

 

Ann arbor stage

  

0.068

  

0.674

  

0.111

 I–IIE

10

14.0 ± 10.5

 

6

4.6 ± 4.3

 

9

1.8 ± 2.8

 

 III–IVE

13

19.4 ± 6.8

 

9

4.2 ± 5.6

 

8

4.7 ± 4.6

 

LDH

  

0.156

  

0.262

  

0.618

 ≤245

12

14.9 ± 11.3

 

7

6.2 ± 6.3

 

8

3.5 ± 5.3

 

 >245

11

19.3 ± 4.5

 

8

2.7 ± 3.0

 

9

3.0 ± 2.4

 

IPI scores

  

0.114

  

0.368

  

0.176

 ≤2

14

15.0 ± 9.9

 

9

5.5 ± 5.8

 

11

2.8 ± 4.6

 

 >2

9

20.2 ± 6.1

 

6

2.7 ± 3.1

 

6

3.8 ± 2.2

 
  1. PET positron emission tomography, CT computed tomography, SUVmax the maximum standardized uptake value, ECOG eastern cooperative oncology group, LDH lactate dehydrogenase, IPI international prognostic index, SD standard deviation
  2. aBulky disease, tumor diameter >10 cm